Opportunity Information: Apply for PA 15 082
Apply for PA 15 082
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Drug Abuse Prevention Intervention Research (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Jan 9, 2015 and posted on Jan 9, 2015.
- Applicants must submit their applications by Sep 7, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Public and State controlled institutions of higher education Private institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Small businesses Special district governments For profit organizations other than small businesses State governments County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Native American tribal governments (Federally recognized).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Drug Abuse Prevention Intervention Research (R01) opportunity (Funding Opportunity Number PA-15-082) is a National Institutes of Health discretionary grant program that supported R01 research projects focused on improving the science of drug use prevention. The central aim of the FOA was to fund studies that use rigorous scientific methods to test theoretically derived hypotheses about how and why prevention works, for whom it works, and under what conditions it works. A major emphasis is on advancing prevention science across the lifespan and within diverse populations and real-world settings, rather than limiting research to narrowly defined groups or controlled environments.
The FOA highlighted several priority areas. First, it encouraged the development of novel prevention approaches grounded in theory and informed by an understanding of cognitive, behavioral, and social processes related to drug use initiation and escalation. Second, it supported research on the efficacy and effectiveness of prevention interventions and programs, which can include controlled trials to establish whether an intervention can work under optimal conditions as well as studies examining performance in typical community, school, healthcare, or other service settings. Third, it sought work on optimizing how evidence-based prevention is selected, integrated, implemented, and sustained over time. This includes attention to systems-level issues (such as organizational readiness, policy environments, workforce capacity, and service delivery structures) and health economic factors (such as cost, cost-effectiveness, and resource allocation) that can determine whether prevention programs are scalable and durable. Fourth, the FOA encouraged the use or development of methodologies suited to studying complex aspects of prevention science, recognizing that prevention often involves multicomponent interventions, layered contexts (families, schools, neighborhoods, digital environments), and outcomes that unfold over long time horizons.
In terms of administrative details, this was a grant mechanism under the R01 funding instrument, categorized under education and health, and aligned with CFDA 93.279 (Drug Abuse and Addiction Research Programs). Cost sharing or matching was not required. The FOA was posted and created on January 9, 2015, with an original and final closing date of September 7, 2017, and it was archived on October 8, 2017, indicating it is no longer open under that specific announcement.
Eligibility was broad and included many types of U.S. and non-U.S. organizations. Eligible applicants listed in the source data included public and private institutions of higher education, nonprofit organizations (both with and without 501(c)(3) status), for-profit organizations (including small businesses and other for-profits), and a range of governmental entities (city/township, county, state, special district governments, and independent school districts), along with public housing authorities and Indian housing authorities. The FOA also explicitly included a wide set of additional eligible applicants such as Historically Black Colleges and Universities, Hispanic-serving institutions, Tribally Controlled Colleges and Universities, Alaska Native and Native Hawaiian-serving institutions, Asian American and Native American Pacific Islander-serving institutions, faith-based and community-based organizations, eligible federal agencies, U.S. territories or possessions, and tribal governments (federally recognized and other than federally recognized). Importantly, foreign organizations and foreign institutions were eligible to apply, non-U.S. components of U.S. organizations could participate, and foreign components were allowed as defined by NIH policy.
The full announcement was hosted through the NIH grants guide at http://grants.nih.gov/grants/guide/pa-files/PA-15-082.html. For access or technical issues, the contact listed was the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs)
What is the Drug Abuse Prevention Intervention Research (R01) opportunity (PA-15-082)?
PA-15-082 was a National Institutes of Health (NIH) discretionary grant opportunity that supported R01 research projects focused on improving the science of drug use prevention. It funded studies designed to strengthen understanding of how prevention works, why it works, who it works for, and the conditions under which it works.
What was the central aim of this FOA?
The central aim was to fund studies that use rigorous scientific methods to test theoretically derived hypotheses about prevention mechanisms and outcomes, including how and why prevention works, for whom it works, and under what conditions it works.
What types of research were emphasized?
The FOA emphasized prevention research that advances prevention science across the lifespan and within diverse populations and real-world settings, rather than focusing only on narrowly defined groups or highly controlled environments.
What were the main priority areas described in the FOA?
The FOA highlighted four main priority areas: (1) developing novel, theory-grounded prevention approaches informed by cognitive, behavioral, and social processes related to drug use initiation and escalation; (2) studying the efficacy and effectiveness of prevention interventions and programs; (3) optimizing the selection, integration, implementation, and long-term sustainment of evidence-based prevention; and (4) using or developing methods suited to studying complex, multi-component prevention efforts across layered contexts and long time horizons.
Did the FOA encourage new (novel) prevention approaches?
Yes. It encouraged development of novel prevention approaches grounded in theory and informed by cognitive, behavioral, and social processes that influence drug use initiation and escalation.
Did the FOA support studies of both efficacy and effectiveness?
Yes. It supported research on both efficacy and effectiveness of prevention interventions and programs. This included controlled trials to test whether an intervention can work under optimal conditions, as well as studies examining performance in typical real-world settings such as communities, schools, healthcare, and other service environments.
What did the FOA mean by improving implementation and sustainment of evidence-based prevention?
It sought research on how evidence-based prevention is selected, integrated, implemented, and sustained over time. This included attention to systems-level factors and health economic factors that affect whether prevention programs can scale and remain durable.
What kinds of systems-level factors were specifically mentioned?
Examples of systems-level issues mentioned included organizational readiness, policy environments, workforce capacity, and service delivery structures that can shape implementation and long-term sustainment.
Were cost and economic considerations part of the FOA?
Yes. The FOA explicitly noted health economic factors such as cost, cost-effectiveness, and resource allocation as considerations that can influence scalability and durability of prevention programs.
Did the FOA encourage methodological innovation?
Yes. It encouraged the use or development of methodologies suited to prevention science, recognizing that prevention often involves multicomponent interventions, layered contexts (for example, families, schools, neighborhoods, and digital environments), and outcomes that unfold over long time horizons.
What grant mechanism was used?
This opportunity used the NIH R01 funding instrument.
What program area did this opportunity fall under?
It was categorized under education and health.
What CFDA number was associated with this opportunity?
The opportunity was aligned with CFDA 93.279 (Drug Abuse and Addiction Research Programs).
Was cost sharing or matching required?
No. Cost sharing or matching was not required.
Is PA-15-082 currently open for applications?
No. The FOA had an original and final closing date of September 7, 2017, and it was archived on October 8, 2017. That indicates the announcement is no longer open under that specific FOA number.
When was the FOA posted?
The FOA was posted and created on January 9, 2015.
Who was eligible to apply?
Eligibility was broad and included many types of U.S. and non-U.S. organizations. The listed eligible applicants included public and private institutions of higher education; nonprofit organizations (with or without 501(c)(3) status); for-profit organizations (including small businesses and other for-profits); and governmental entities such as city/township, county, state, special district governments, and independent school districts, plus public housing authorities and Indian housing authorities.
Were minority-serving institutions explicitly included as eligible applicants?
Yes. The FOA explicitly included categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities, Alaska Native and Native Hawaiian-serving institutions, and Asian American and Native American Pacific Islander-serving institutions.
Were faith-based and community-based organizations eligible?
Yes. Faith-based and community-based organizations were explicitly listed among eligible applicants.
Could tribal governments apply?
Yes. Tribal governments (federally recognized and other than federally recognized) were explicitly listed as eligible applicants.
Were U.S. territories or possessions eligible?
Yes. U.S. territories or possessions were explicitly included among eligible applicants.
Were federal agencies eligible to apply?
Yes. Eligible federal agencies were explicitly listed as eligible applicants.
Could foreign organizations apply?
Yes. Foreign organizations and foreign institutions were eligible to apply under the FOA.
Could a U.S. organization include non-U.S. components in the project?
Yes. Non-U.S. components of U.S. organizations could participate, and foreign components were allowed as defined by NIH policy.
Where was the full funding announcement posted?
The full announcement was hosted through the NIH grants guide at: http://grants.nih.gov/grants/guide/pa-files/PA-15-082.html
Who should be contacted for access or technical issues related to the announcement?
For access or technical issues, the contact listed was the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: SHRP2 Education Connection
Previous opportunity: Drug Abuse Prevention Intervention Research (R03)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 15 082
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 15 082) also looked into and applied for these:
| Funding Opportunity |
|---|
| BRAIN Initiative Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR) (R41/R42) Apply for PAR 15 090 Funding Number: PAR 15 090 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| BRAIN Initiative Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR) (R43/R44) Apply for PAR 15 091 Funding Number: PAR 15 091 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21) Apply for PAR 15 092 Funding Number: PAR 15 092 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Basic Cancer Research in Cancer Health Disparities (R01) Apply for PAR 15 093 Funding Number: PAR 15 093 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| NIDA Translational Avant Garde Award for Development of Medication to Treat Substance Use Disorders (UH2/UH3) Apply for RFA DA 15 017 Funding Number: RFA DA 15 017 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| Assay Validation For High Quality Markers For NCI Supported Clinical Trials (UH2/UH3) Apply for PAR 15 095 Funding Number: PAR 15 095 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Assay Validation For High Quality Markers For NCI Supported Clinical Trials (UH3) Apply for PAR 15 096 Funding Number: PAR 15 096 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Prevention Research in Mid Life Adults (R21) Apply for PA 15 097 Funding Number: PA 15 097 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Prevention Research in Mid Life Adults (R01) Apply for PA 15 098 Funding Number: PA 15 098 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Reductions in Illicit Drug Use and Functional Outcomes (R21/R33) Apply for PA 15 099 Funding Number: PA 15 099 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Maternal Nutrition and Pre pregnancy Obesity Effects on Mothers, Infants and Children (R01) Apply for PA 15 100 Funding Number: PA 15 100 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01) Apply for PAR 15 104 Funding Number: PAR 15 104 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,500,000 |
| Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54) Apply for PAR 15 103 Funding Number: PAR 15 103 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Developing Technologies and Tools to Monitor HIV Brain Reservoirs and How They May be Altered by Exposure to Substances of Abuse (R21/R33) Apply for RFA DA 15 018 Funding Number: RFA DA 15 018 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Gene Environment Interplay in Substance Use Disorders (R01) Apply for PA 15 110 Funding Number: PA 15 110 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Gene Environment Interplay in Substance Use Disorders (R03) Apply for PA 15 111 Funding Number: PA 15 111 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Gene Environment Interplay in Substance Use Disorders (R21) Apply for PA 15 112 Funding Number: PA 15 112 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01) Apply for RFA DA 16 001 Funding Number: RFA DA 16 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Mentored Clinical Scientists Development Program Award in Drug Abuse and Addiction (K12) Apply for PAR 15 119 Funding Number: PAR 15 119 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Identification of Genetic and Genomic Variants by Next Gen in Sequencing Non human Animal Models (U01) Apply for PAR 15 120 Funding Number: PAR 15 120 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 15 082", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
